Pre-treatment evaluation should consider: Comprehensive medical history, specifically asking about prior pancreatitis episodes Assessment of alcohol consumption patterns Lipid panel to identify hypertriglyceridemia (triglycerides 500 mg/dL warrant management to reduce risk) Evaluation for gallbladder disease, particularly in patients with obesity The FDA continues post-marketing surveillance through the FAERS database, and healthcare providers are encouraged to report any suspected pancreatitis cases to the FDA MedWatch program
If you get stuck on an island and have one thing to protect your life, one thing is glutathione
Youve heard the brand names Ozempic, Wegovy, Mounjaro, Zepbound
H., Rosner, B., Sluss, P
Early communication, dose review, and coordinated care reduce risk and keep treatment safer
L., Da Silva Soares De Souza, M., De Souza, G